CARM icon

Carisma Therapeutics
CARM

Overview Fund Activity

26 hedge funds and large institutions have $1.95M invested in Carisma Therapeutics in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.

Holders
26
Holders Change
-1
Holders Change %
-3.7%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
7
Reduced
4
Closed
6
Calls
–
Puts
$8K
Net Calls
-$8K
Net Calls Change
+$29K

Top Buyers

1
VKH
1
Virtu KCG Holdings
New York
$175K
2
SIM
2
Spark Investment Management
New York
$148K
3
ARTA
3
A.R.T. Advisors
New York
$77K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$324K
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$83K

Top Sellers

1
FP
1
Flagship Pioneering
Massachusetts
$0
2
GCP
2
GSA Capital Partners
United Kingdom
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
EGA
4
Eagle Global Advisors
Texas
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GCP
26
GSA Capital Partners
United Kingdom
– -$207K -4,695 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$65K -1,480 Closed
EGA
28
Eagle Global Advisors
Texas
– -$58K -1,327 Closed
Goldman Sachs
29
Goldman Sachs
New York
– -$35K -791 Closed
FPF
30
FNY Partners Fund
New York
– -$11K -250 Closed
1
2